What we do…
Knome specializes in the interpretation of human whole genomes.With our knomeBASE and knomeDISCOVERYproducts, we support academic, pharmaceutical, and biotech researchers with the services and software they need to investigate the genetic basis of disease and drug response.
Through our platform group, we provide clinics with large-scale information systems to 1) manage whole genome sequence data and 2) help physicians interpret genomes in order to inform preventative, diagnostic, and treatment decisions.
Latest News
11 Jan 2012 Bio-IT World
Knome’s New CEO Signals New Directions in Genome Interpretation
Bio IT World’s Kevin Davies covers Knome’s announcement of its new CEO and discussion of 2012 direction. Full article.
11 Jan 2012 Xconomy
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes
Luke Timmerman of Xconomy covers Knome’s announcement of a new CEO and signing of large deal with Johns Hopkins. Full article
Expands management team as company pursues new growth opportunities CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has appointed Martin Tolar, MD, PhD, as the company’s Chief Executive Officer. In … more
09 Jan 2012
Knome Selected as Technology Partner by Johns Hopkins for Landmark 1,000 Genomes Asthma Research
Knome’s informatics and software tools to be used to interpret whole genomes of African American and African Caribbean asthma patients CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has … more
09 Jan 2012
Knome Expands Scientific Advisory Board
David Goldstein and Dr. Yaniv Erlich bring genomics expertise as company pursues future growth CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to … more
